Kythera Biopharmaceuticals Inc (NASDAQ:KYTH) was in 10 hedge funds' portfolio at the end of March. KYTH investors should be aware of an increase in support from the world's most elite money managers lately.

LOS ANGELES, June 6, 2013 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the Goldman Sachs 34th Annual Global Healthcare ...

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of prescription products for the aesthetic medicine market.

These stocks are Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Keryx Biopharmaceuticals (NASDAQ:KERX), Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), and Kythera Biopharmaceuticals Inc (NASDAQ:KYTH).

Among the biggest gainers was Kythera Biopharmaceuticals Inc., rising 14 percent to $25.39. The gain came after the Calabasas developer of injectable fat dissolver for the aesthetic market made a presentation at an investor meeting.

These stocks are Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Keryx Biopharmaceuticals (NASDAQ:KERX), Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Endocyte, Inc. (NASDAQ:ECYT), and Kythera Biopharmaceuticals Inc (NASDAQ:KYTH). This group ...

(RTTNews.com) - KYTHERA Biopharmaceuticals, Inc. ( KYTH ) will present at the Goldman Sachs 34th Annual Global Healthcare Conference in Palos Verdes, CA.

These stocks are Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), Kythera Biopharmaceuticals Inc (NASDAQ:KYTH), Endocyte, Inc. (NASDAQ:ECYT), Intercept Pharmaceuticals Inc (NASDAQ:ICPT), and Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL).

Big pharma drug delivery partnering company profiles Abbott Actavis Inc (formerly Watson Pharmaceuticals) Actavis (merged with Watson Pharmaceuticals Oct 2012) Actelion Allergan Amgen Astellas AstraZeneca Baxter International Bayer Biogen Idec ...